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Introduction
According to Mayer al. 5 and Nuechterlein et al. 6 The objective of this review was to comprehensively assess the literature on EI in Schizophrenia spectrum disorders, aiming to describe and critically evaluate the extent to which this concept could be clinically useful.
Methods
For this review, searches for relevant articles were run on the MEDLINE/PubMed, Google Scholar, Cochrane, LILACS, Embase and SciELO databases.
Searches were performed during October of 2017 for studies published from inception to 2017 and used the following terms for MEDLINE/PubMed: ("Emotional
Intelligences" OR "Intelligence, Emotional" OR "Intelligences, Emotional" OR "Social Intelligence" OR "Intelligence, Social" OR "Intelligences, Social" OR "Social
Intelligences") AND (MSCEIT OR "Mayer-Salovey-Caruso Emotional Intelligence Test") AND ("Schizophrenias" OR "Schizophrenic Disorders" OR "Disorder, Schizophrenic" OR "Disorders, Schizophrenic" OR "Schizophrenic Disorder"
OR "Schizophrenia" OR "Schizophrenia Spectrum and
Other Psychotic Disorders" OR "Schizophrenia, Paranoid"
OR "Schizophrenia, Disorganized" OR "Schizophrenia, Childhood" OR "Schizophrenia, Catatonic").
The reference lists of papers included were manually searched for additional pertinent references. The abstracts of all the articles identified were read by two authors (KPL and FDMPM) to select those that would be included in our analysis. After we had selected articles on the basis of their abstracts, the full texts were read by three authors, to ensure the best evaluation possible.
We searched for relevant original articles in English, Portuguese or Spanish that used standardized methods to access Emotional Intelligence in the manner that this construct was described by Mayer and Solomon. We were specifically searching for studies involving adult populations that compared EI between subjects with schizophrenia spectrum disorders and healthy controls or subjects with different mental disorders.
Results
The first issue in this review was related to the instrument. The only instrument that appropriately evaluated the EI as a construct was the MSCEIT. Because of this, for the purpose of this study we focused only on articles that used MSCEIT to evaluate EI. There are two main reasons for this choice: first, the Mayer and Salovey model's theoretical approach is more tenable than those of other models, in the researchers' opinion.
Second, MSCEIT is currently the only ability test that covers all four dimensions of EI. Third, as already explained, the MSCEIT has good validity, which has not been observed for other instruments. 7 The search returned 30 articles assessing associations between emotional abilities and schizophrenia spectrum disorders. After reading abstracts and full text articles, 19 were selected because they reported using all four branches of the MSCEIT to evaluate EI scores. The studies reviewed found significant deficiencies in the overall MSCEIT performance score and also in scores for each of its four components in patients with schizophrenia spectrum disorders, when compared to healthy subjects. Kee et al., 19 Dawson et al. 11 and Mao et al. 21 found that understanding and management of emotions were the most deficient. Furthermore, They report that the MSCEIT has adequate internal consistency and reliability to evaluate the sample. They also found a shift in the EI factor structure in the sample when compared to healthy subjects.
-Small sample.
-Patients were selected from a clinical trial of CET.
Schizophrenia
Eack 13 Retrospective 64 clinical subjects (same as the previous study -Eack et al. 12 ) + normative sample with 2563 subjects
They confirm the previous finding of a shift in the factor structure of EI in patients with schizophrenia.
-Small clinical sample.
-Absence of demographically-matched controls known to be free from mental disorders.
Eack 14 Randomized controlled trial 58 early-course outpatients with schizophrenia spectrum disorders They found CET to be an effective approach for improving cognitive deficits in the sample.
Eack 15 Clinical trial 58 early-course schizophrenia outpatients They found CET had an impact on EI measures and correlated this result with the functional outcome.
-Unable to discard type I error.
Frajo-Apor 16 Cross-sectional 56 paranoid schizophrenia patients and 84 healthy controls They found that the clinical sample had poorer EI than the controls. They found this effect was mediated by non-social cognition.
-They suggest that more tools could be used to assess EI. -Different treatments for different patients in the clinical sample. -Some of the patients were symptomatic during the tests.
Frajo-Apor 17 Cross-sectional 58 schizophrenia outpatients and 60 bipolar disorder I outpatients They demonstrate that the schizophrenia sample performed worse on the MSCEIT when compared to the bipolar disorder patients (except for the emotion perception branch). They also correlated the difference to nonsocial cognition.
-They used the BACS to evaluate non-social cognition in both groups, although it is only validated for schizophrenia samples. -Some patients were not in full remission.
Green 18 Cross-sectional -50 individuals with prodromal risk syndrome for psychosis + 34 demographically comparable controls. -81 first-episode schizophrenia + 46 demographically comparable controls. -53 chronic schizophrenia + 47 demographically comparable controls.
They found the clinical samples to have impairment on general MSCEIT performance. There was no significant difference in MSCEIT performance during the different phases of illness, except for the perception of emotions branch.
-Some patients were using antipsychotic medications. -The sample was mainly young. -Unable to establish causal effects.
Kee 19 Cross-sectional 50 schizophrenia and 39 non-psychiatric controls
The clinical sample had poorer EI than controls. The MSCEIT score was worse in patients with negative symptoms and those with poorer community functioning.
-Unable to evaluate if the severity of symptoms was related to the chronicity of disease, to emotional traits or to the long-term exposure to antipsychotic medications.
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Schizophrenia
Lin 20 Cross-sectional 174 schizophrenia and 20 schizoaffective disorder
They found MSCEIT to have a twofactor structure in the schizophrenia sample. Factor 1 broadly associated with the regulation and management of emotions and factor 2 related with facial emotion perception.
-Unable to establish causal effects.
Mao 21 Cross-sectional 76 schizophrenia and 738 healthy controls The violent group performed worse on MSCEIT than the nonviolent group. The study also found that the severity of symptoms had a strong inverse correlation with MSCEIT performance.
-The sample was in a secure forensic environment. -The sample was majority male.
Wojtalik 24 Cross-sectional 51 early-course, stabilized schizophrenia or schizoaffective disorder patients. Both groups of patients exhibited significantly lower performance in terms of total MSCEIT scores. Schizophrenia patients exhibited impairment in perception, facilitation and understanding of emotions in relation to the control group.
-Unable to evaluate causal effects.
-Small sample size and exploratory nature.
Adapted from Kun et al. 27 BACS = Brief Assessment of Cognition in Schizophrenia; CET = Cognitive Enhancement Therapy; EI = emotional intelligence; IQ = intelligence quotient; MSCEIT = Multifactor Emotional Intelligence Scale. According to Mayer et al., in healthy individuals, the lowlevel "experiential" factor contains both perception and facilitation, while the "strategic" high level factor contains understanding and management of emotions. 3 In contrast, in subjects with schizophrenia spectrum disorders, the composition of the "experiential" and "strategic" factors is (I) perception and understanding and (II) facilitation and management, respectively, as found by Eack et al. 12 and Lin et al. 20 It can be noted that this population's EI is structured differently from that of healthy controls, since facilitation and understanding of emotions are at different levels of processing.
Eack et al. used multi-group confirmatory factor analysis to test factorial invariance of the MSCEIT across schizophrenia. 13 The sample comprised patients inverse correlation between test performance and disease duration. 12 Kee et al. also observed a significant correlation between lower MSCEIT scores and negative and disorganized symptoms, as well as poorer functioning in the community. 19 Interestingly, individuals with schizophrenia had subjective deficits in EI compared to healthy controls. A better EI result in this group of patients was associated with a higher probability of living independently, as reported by Tabak et al. 28 In another analysis, a group of researchers administered the MSCEIT to three groups representing the different phases of schizophrenia: prodromal, first episode and chronic schizophrenia. 18 A demographically comparable healthy control group was selected for each of these groups. Impairments were observed in all three clinical groups when compared to their respective controls. Additionally, there was a significant phase effect in relation to the MSCEIT perception of emotions branch, with a decline in both later disease stage groups. However, there was no evidence of worsening or improvement of emotional abilities with disease progression. Thus, as the impairment also applies to the earlier phases of the disease, it is suggested that daily functioning relationships that have been established for the chronic phase can also be applied to these initial phases.
In common with Green et al., 18 McCleery et al. also investigated the relationship between the emotional abilities of patients with schizophrenia and the chronicity of the disease. 22 The MSCEIT scale was administered to 41 patients with schizophrenia at baseline and after about five years. Additionally, the Role Functioning Scale (RFS) was used to evaluate longitudinal associations between EI and community functioning. The results showed that there were no changes in emotional abilities over the period. Furthermore, EI had no significant longitudinal influence on community functioning after five years.
However, the study reports that, according to much of the literature, there is an association between EI and community functioning, only cross-sectional, rather than longitudinal. Therefore, the study suggests that the EI of patients with schizophrenia, rather than having longterm consequences, exhibits short-term influences.
Heterogeneity of scores on the MSCEIT was observed in schizophrenia groups. O'Reilly et al. 23 prospectively 
Discussion
Overall, the findings of this review indicate that individuals with schizophrenia spectrum disorders have poor performance in EI assessed by MSCEIT compared to healthy controls and that these deficits could be related to the severity of symptoms. It was observed that both global EI and the score for each of the scale's dimensions are decreased in most disorders studied.
These findings were consistent with the expected results. Lower EI scores are related to worse psychic wellness and possibly to a higher risk of developing mental disorders.
There are some studies indicating that the emotional intelligence of patients with schizophrenia spectrum disorders is structured differently from that of healthy controls in terms of EI processing levels.
In controls, the "experiential" factor contains both perception and facilitation and the "strategic" factor contains understanding and management of emotions.
In contrast, in subjects with schizophrenia spectrum disorders, the composition of the "experiential" and "strategic" factor composition is (I) perception and understanding and (II) facilitation and management, respectively as reported by Eack et al. 12 and Lin et al. 20 17 However, none of the other studies compared these two mental disorders, so more research is necessary to clarify this correlation.
Limitations and future research directions
Most of the items that made up this review are analytical case-control studies, which detected changes in EI scores in subjects with schizophrenia spectrum disorders and healthy controls. Thus, confirmation of a causal relationship between low EI scores and the presence of a schizophrenia spectrum disorder is not possible. Additionally, the fact that not all studies regard intellectual ability as a variable to be investigated is also a limitation. According to Copestake et al., 31 this is because the negative associations found between EI scores and mental disorders in most studies may be more related to intellectual rather than emotional impairment. 34 Inconsistencies between instruments could be considered a consequence of the lack of a uniform definition of the construct, an aspect that should be explored further.
Thus, further longitudinal studies should be conducted to elucidate whether there is a causeand-effect relationship between EI and schizophrenia spectrum disorder. New interventions for prevention of mental disorders and enhancement of quality of life can be designed following these studies. Additionally, future studies should assess EI using more than one instrument, enabling broader interpretations of EI.
Differentiation between negative and positive emotions and evaluation of EI over a certain time period should also be included in future studies. 
